Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 14, 2021

SELL
$50.07 - $66.05 $212,547 - $280,382
-4,245 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$56.61 - $80.46 $12,567 - $17,862
-222 Reduced 4.97%
4,245 $267,000
Q1 2021

May 13, 2021

SELL
$86.23 - $125.19 $35,957 - $52,204
-417 Reduced 8.54%
4,467 $415,000
Q4 2020

Mar 02, 2021

SELL
$79.17 - $111.47 $13,775 - $19,395
-174 Reduced 3.44%
4,884 $438,000
Q3 2020

Nov 18, 2020

SELL
$81.91 - $134.94 $17,938 - $29,551
-219 Reduced 4.15%
5,058 $523,000
Q2 2020

Aug 14, 2020

SELL
$54.33 - $89.52 $37,053 - $61,052
-682 Reduced 11.44%
5,277 $646,000
Q1 2020

May 18, 2020

SELL
$49.34 - $68.76 $12,532 - $17,465
-254 Reduced 4.09%
5,959 $484,000
Q4 2019

Feb 13, 2020

BUY
$51.21 - $59.06 $313,046 - $361,033
6,113 Added 6113.0%
6,213 $390,000
Q4 2019

Feb 12, 2020

SELL
$51.21 - $59.06 $334,350 - $385,602
-6,529 Reduced 98.49%
100 $335,000
Q3 2019

Oct 10, 2019

BUY
$40.6 - $57.2 $12,992 - $18,304
320 Added 5.07%
6,629 $347,000
Q2 2019

Jul 15, 2019

BUY
$39.92 - $53.86 $251,855 - $339,802
6,309 New
6,309 $305,000
Q1 2019

Apr 24, 2019

SELL
$48.23 - $66.16 $398,138 - $546,150
-8,255 Closed
0 $0
Q4 2018

Jan 31, 2019

SELL
$55.63 - $73.24 $25,200 - $33,177
-453 Reduced 5.2%
8,255 $489,000
Q3 2018

Jan 31, 2019

BUY
$52.05 - $66.51 $16,968 - $21,682
326 Added 3.89%
8,708 $573,000
Q2 2018

Jul 11, 2018

SELL
$48.33 - $55.64 $69,643 - $80,177
-1,441 Reduced 14.67%
8,382 $423,000
Q1 2018

May 16, 2018

SELL
$44.44 - $54.39 $15,998 - $19,580
-360 Reduced 3.54%
9,823 $517,000
Q4 2017

Jan 11, 2018

SELL
$37.77 - $47.75 $80,752 - $102,089
-2,138 Reduced 17.35%
10,183 $473,000
Q3 2017

Oct 30, 2017

BUY
$34.14 - $40.45 $420,638 - $498,384
12,321
12,321 $498,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $291M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Capital Asset Advisory Services LLC Portfolio

Follow Capital Asset Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.